
Results
184
Companies which are potentially undervalued and in an acceptable financial position.
184 companies
Trulieve Cannabis
Market Cap: US$1.7b
Operates as a cannabis retailer in the United States.
TRLV
US$9.30
7D
4.6%
1Y
24.0%
High Tide
Market Cap: CA$283.8m
Engages in the cannabis retail business in Canada, the United States, and internationally.
HITI
CA$3.27
7D
3.3%
1Y
0.6%
Innovent Biologics
Market Cap: HK$166.3b
A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, Europe, and internationally.
1801
HK$95.55
7D
10.2%
1Y
9.5%
Oxford Biomedica
Market Cap: UK£589.5m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£4.87
7D
-14.0%
1Y
9.9%
Hypera
Market Cap: R$14.9b
Operates as a pharmaceutical company in Brazil.
HYPE3
R$21.16
7D
-1.4%
1Y
-7.7%
CorMedix
Market Cap: US$590.7m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$7.30
7D
-2.9%
1Y
-36.5%
Yunnan Baiyao GroupLtd
Market Cap: CN¥90.7b
Engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
000538
CN¥50.83
7D
-1.7%
1Y
-9.2%
UCB
Market Cap: €43.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€226.20
7D
1.3%
1Y
20.9%
Green Thumb Industries
Market Cap: CA$2.1b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$10.19
7D
-0.2%
1Y
-10.0%
Elanco Animal Health
Market Cap: US$11.1b
An animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.
ELAN
US$22.73
7D
-11.2%
1Y
30.4%
Kuros Biosciences
Market Cap: CHF 914.8m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 23.06
7D
0.4%
1Y
-12.8%
Dong-E-E-Jiao
Market Cap: CN¥34.2b
Engages in the research, development, production, and sale of donkey-hide gelatin and related products in China and internationally.
000423
CN¥53.62
7D
-1.8%
1Y
5.3%
Prestige Consumer Healthcare
Market Cap: US$2.5b
Develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally.
PBH
US$53.60
7D
3.1%
1Y
-17.9%
Bavarian Nordic
Market Cap: DKK 13.5b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 177.10
7D
-1.2%
1Y
-25.4%
Diaceutics
Market Cap: UK£126.5m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.49
7D
3.1%
1Y
8.4%
Amoy Diagnostics
Market Cap: CN¥7.2b
Engages in research and development, production, sale, and supporting services of tumor precision medical diagnostic products in China and internationally.
300685
CN¥18.68
7D
5.4%
1Y
-22.0%
Dong-A ST
Market Cap: ₩382.7b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩39,700.00
7D
6.6%
1Y
-8.2%
Duopharma Biotech Berhad
Market Cap: RM 1.2b
Researches, develops, manufactures, markets, sells, imports, and distributes pharmaceutical products and medicines in Malaysia and internationally.
DPHARMA
RM 1.22
7D
0.8%
1Y
-6.9%
Cresco Labs
Market Cap: CA$465.8m
Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.
CL
CA$1.08
7D
9.1%
1Y
-23.4%
Fennec Pharmaceuticals
Market Cap: US$380.0m
Operates as a commercial stage biopharmaceutical company in the United States.
FENC
US$12.78
7D
26.4%
1Y
38.3%
Journey Medical
Market Cap: US$177.3m
A commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
DERM
US$6.32
7D
-1.3%
1Y
-26.0%
Decibel Cannabis
Market Cap: CA$63.5m
An integrated cannabis company, engages in the cannabis cultivation, processing, and sale of cannabis flower products in Canada.
DB
CA$0.11
7D
0%
1Y
-4.3%
China Resources Pharmaceutical Group
Market Cap: HK$30.8b
An investment holding company, engages in the manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and internationally.
3320
HK$4.91
7D
0.9%
1Y
-6.4%
United Laboratories International Holdings
Market Cap: HK$17.9b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$9.07
7D
-0.4%
1Y
-39.0%
Daewoong Pharmaceutical
Market Cap: ₩1.5t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩130,100.00
7D
5.3%
1Y
0.6%
Perrigo
Market Cap: US$1.8b
Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.
PRGO
US$12.85
7D
19.2%
1Y
-44.3%
Dermapharm Holding
Market Cap: €2.0b
Manufactures and sells off-patent branded pharmaceutical products in Germany, Italy, France, Austria, Switzerland, Spain, Portugal, the Netherlands, Croatia, Poland, Ukraine, the United States, and China.
DMP
€39.75
7D
-4.0%
1Y
22.7%
Laboratorios Farmaceuticos Rovi
Market Cap: €3.0b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€58.35
7D
-1.0%
1Y
7.9%
Tianjin Ringpu Bio-TechnologyLtd
Market Cap: CN¥8.2b
Engages in the research and development, production, and sale of veterinary raw materials, pharmaceutical preparation, functional additives, and veterinary biological products.
300119
CN¥18.12
7D
2.5%
1Y
-17.6%
Tasly Pharmaceutical Group
Market Cap: CN¥23.2b
Engages in the research, development, production, and sale of pharmaceuticals in China.
600535
CN¥15.53
7D
-2.0%
1Y
-4.7%
Imeik Technology DevelopmentLtd
Market Cap: CN¥31.2b
Engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China.
300896
CN¥103.63
7D
-1.3%
1Y
-44.4%
ACADIA Pharmaceuticals
Market Cap: US$5.1b
A biopharmaceutical company, focuses on the development and commercialization of medicines for neurological and rare disease in North America.
ACAD
US$29.41
7D
8.3%
1Y
15.6%
Cellectis
Market Cap: €182.3m
A clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications.
ALCLS
€2.51
7D
3.0%
1Y
9.0%
H. Lundbeck
Market Cap: DKK 39.9b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 41.48
7D
2.5%
1Y
17.7%
Avantor
Market Cap: US$9.3b
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
AVTR
US$13.77
7D
0.7%
1Y
8.8%
Amphastar Pharmaceuticals
Market Cap: US$863.9m
A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
AMPH
US$20.42
7D
2.6%
1Y
-32.7%